These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35693071)

  • 1. MYBL2 accelerates epithelial-mesenchymal transition and hepatoblastoma metastasis via the Smad/SNAI1 pathway.
    Wei M; Yang R; Ye M; Zhan Y; Liu B; Meng L; Xie L; Du M; Wang J; Gao R; Chen D; Dong R; Dong K
    Am J Cancer Res; 2022; 12(5):1960-1981. PubMed ID: 35693071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymosin β4 promotes hepatoblastoma metastasis via the induction of epithelial-mesenchymal transition.
    Fu X; Cui P; Chen F; Xu J; Gong L; Jiang L; Zhang D; Xiao Y
    Mol Med Rep; 2015 Jul; 12(1):127-32. PubMed ID: 25695679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2/Smad/METTL3 signaling axis.
    Song C; Zhou C
    J Exp Clin Cancer Res; 2021 Feb; 40(1):62. PubMed ID: 33563300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma.
    Chen L; Tian X; Gong W; Sun B; Li G; Liu D; Guo P; He Y; Chen Z; Xia Y; Song T; Guo H
    Cancer Biol Med; 2019 Feb; 16(1):89-100. PubMed ID: 31119049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect and mechanism of miR-30e-5p targeting SNAI1 to regulate epithelial-mesenchymal transition on pancreatic cancer.
    Liang Z; Tang S; He R; Luo W; Qin S; Jiang H
    Bioengineered; 2022 Apr; 13(4):8013-8028. PubMed ID: 35300562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
    Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
    Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition.
    Moes M; Le Béchec A; Crespo I; Laurini C; Halavatyi A; Vetter G; Del Sol A; Friederich E
    PLoS One; 2012; 7(4):e35440. PubMed ID: 22514743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
    Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
    Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance via radixin-mediated increase of P-glycoprotein membrane expression during SNAI1-induced epithelial-mesenchymal transition in HepG2 cells.
    Kamioka H; Edaki K; Kasahara H; Tomono T; Yano K; Ogihara T
    J Pharm Pharmacol; 2021 Dec; 73(12):1609-1616. PubMed ID: 34313784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFATc1 promotes epithelial-mesenchymal transition and facilitates colorectal cancer metastasis by targeting SNAI1.
    Shen T; Yue C; Wang X; Wang Z; Wu Y; Zhao C; Chang P; Sun X; Wang W
    Exp Cell Res; 2021 Nov; 408(1):112854. PubMed ID: 34597678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer.
    Ren F; Wang L; Shen X; Xiao X; Liu Z; Wei P; Wang Y; Qi P; Shen C; Sheng W; Du X
    Am J Cancer Res; 2015; 5(4):1542-52. PubMed ID: 26101717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. circ-MYBL2 Serves As A Sponge For miR-361-3p Promoting Cervical Cancer Cells Proliferation And Invasion.
    Wang J; Li H; Liang Z
    Onco Targets Ther; 2019; 12():9957-9964. PubMed ID: 31819492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer.
    Cui Y; Song Y; Yan S; Cao M; Huang J; Jia D; Liu Y; Zhang S; Fan W; Cai L; Li C; Xing Y
    Aging (Albany NY); 2020 Oct; 12(20):20047-20068. PubMed ID: 33099540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-182 drives colonization and macroscopic metastasis via targeting its suppressor SNAI1 in breast cancer.
    Zhan Y; Li X; Liang X; Li L; Cao B; Wang B; Ma J; Ding F; Wang X; Pang D; Liu Z
    Oncotarget; 2017 Jan; 8(3):4629-4641. PubMed ID: 27894095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and clinical significance of an Epithelial-Mesenchymal Transition inducer, SNAI1, in head and neck carcinoma.
    Zhao H; Ling J; Huang Y; Chang A; Zhuo X
    J Oral Pathol Med; 2021 Feb; 50(2):145-154. PubMed ID: 32945534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma.
    Zhang L; Huang G; Li X; Zhang Y; Jiang Y; Shen J; Liu J; Wang Q; Zhu J; Feng X; Dong J; Qian C
    BMC Cancer; 2013 Mar; 13():108. PubMed ID: 23496980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph node metastasis of cervical cancer via the epithelial-mesenchymal transition pathway.
    Chen Z; Li S; Huang K; Zhang Q; Wang J; Li X; Hu T; Wang S; Yang R; Jia Y; Sun H; Tang F; Zhou H; Shen J; Ma D; Wang S
    Hum Pathol; 2013 Oct; 44(10):2097-105. PubMed ID: 23791009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.